Neoadjuvant Atezolizumab in Cutaneous Melanoma
Clinical trial NCT04020809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04020809
- Sponsor
- The Methodist Hospital Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2025-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.